Family Involvement to Stop the Conversion of Prediabetes to Diabetes

키워드

참고문헌 (71)

1. (2006)[URL]
2. American Diabetes Association, "Diagnosis and classification of diabetes mellitus", Diabetes Care, 37(Suppl 1), pp.S81~S90 (2014)
3. Al-Zahrani JM, "Prevalence of prediabetes, diabetes and its predictors among females in Alkharj, Saudi Arabia : a cross-sectional study", Ann Glob Health, 85, pp.109~ (2019)
4. Yip WCY, "Prevalence of pre-diabetes across ethnicities : a review of impaired fasting glucose(IFG)and impaired glucose tolerance(IGT)for classification of dysglycaemia", Nutrients, 9, pp.1273~ (2017)
5. (2017)[URL]
6. American Diabetes Association, "2. Classification and diagnosis of diabetes : standards of medical care in diabetes-2019", Diabetes Care, 42(Suppl 1), pp.S13~S28 (2019)
7. Hostalek U, "Global epidemiology of prediabetes : present and future perspectives", Clin Diabetes Endocrinol, 5, pp.5~ (2019)
8. Barry E, "Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions", BMJ, 356, pp.i6538~ (2017)
9. (2017)[URL]
10. Ramachandran A, "Diabetes in South-East Asia : an update", Diabetes Res Clin Pract, 103, pp.231~237 (2014)
11. Wan Nazaimoon WM, "Prevalence of diabetes in Malaysia and usefulness of HbA1c as a diagnostic criterion", Diabet Med, 30, pp.825~828 (2013)
12. (2021)[URL]
13. Tabak AG, "Prediabetes : a high-risk state for diabetes development", Lancet, 379, pp.2279~2290 (2012)
14. Nathan DM, "Impaired fasting glucose and impaired glucose tolerance : implications for care", Diabetes Care, 30, pp.753~759 (2007)
15. Forouhi NG, "Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose : the Ely study 1990-2000", Diabet Med, 24, pp.200~207 (2007)
16. Diabetes Prevention Program Research Group, "10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study", Lancet, 374, pp.1677~1686 (2009)
17. Gerstein HC, "Annual incidence and relative risk of diabetes in people with various categories of dysglycemia : a systematic overview and meta-analysis of prospective studies", Diabetes Res Clin Pract, 78, pp.305~312 (2007)
18. Keck JW, "Prediabetes knowledge, attitudes, and practices at an academic family medicine practice", J Am Board Fam Med, 32, pp.505~512 (2019)
19. Mainous AG 3rd, "Is it time to prioritize diabetes prevention in practice?", J Am Board Fam Med, 32, pp.457~459 (2019)
20. Tuso P, "Prediabetes and lifestyle modification : time to prevent a preventable disease", Perm J, 18, pp.88~93 (2014)
21. Lopez-Jaramillo P, "Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome", J Hypertens, 31, pp.223~238 (2013)
22. Garber AJ, "Diagnosis and management of prediabetes in the continuum of hyperglycemia : when do the risks of diabetes begin? : a consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists", Endocr Pract, 14, pp.933~946 (2008)
23. Handelsman Y, "American Association of Clinical Endocrinologists and American College of Endocrinology : clinical practice guidelines for developing a diabetes mellitus comprehensive care plan--2015 : executive summary", Endocr Pract, 21, pp.413~437 (2015)
24. Ely EK, "A national effort to prevent type 2 diabetes : participant-level evaluation of CDC’s National Diabetes Prevention Program", Diabetes Care, 40, pp.1331~1341 (2017)
25. American Diabetes Association, "5. Prevention or delay of type 2 diabetes:standards of medical care in diabetes-2018", Diabetes Care, 41(Suppl 1), pp.S51~S54 (2018)
26. Garber AJ, "Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm : 2018 executive summary", Endocr Pract, 24, pp.91~120 (2018)
27. Farr OM, "Treating prediabetes in the obese : are GLP-1analogues the answer?", Lancet, 389, pp.1371~1372 (2017)
28. Siu AL, "Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force Recommendation Statement", Ann Intern Med, 163, pp.861~868 (2015)
29. Spencer Bonilla G, "What we don’t talk about when we talk about preventing type 2 diabetes-addressing socioeconomic disadvantage", JAMA Intern Med, 176, pp.1053~1054 (2016)
30. Lawal Y, "Prediabetes deserves more attention : a review", Clin Diabetes, 38, pp.328~338 (2020)
31. Kanat M, "Treatment of prediabetes", World J Diabetes, 6, pp.1207~1222 (2015)
32. Garber AJ, "Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm : 2017 executive summary", Endocr Pract, 23, pp.207~238 (2017)
33. Herman WH, "Response to Comment on American Diabetes Association. Standards of Medical Care in Diabetes-2017", Diabetes Care, 40, pp.e94~e95 (2017)
34. "Prediabetes: approach and management" (2019)[URL]
35. Ramachandran A, "The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance(IDPP-1)", Diabetologia, 49, pp.289~297 (2006)
36. Bansal N, "Prediabetes diagnosis and treatment : a review", World J Diabetes, 6, pp.296~303 (2015)
37. Price S, "Lifestyle and pharmacotherapy for weight loss in preventing or delaying diabetes", Am J Lifestyle Med, 12, pp.34~37 (2017)
38. Sjostrom L, "Bariatric surgery and long-term cardiovascular events", JAMA, 307, pp.56~65 (2012)
39. Sjostrom L, "Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery", N Engl J Med, 351, pp.2683~2693 (2004)
40. Garcia-Huidobro D, "Family oriented care : opportunities for health promotion and disease prevention", J Fam Med Dis Prev, 1, pp.2~ (2015)
41. [URL]
42. Weiler DM, "Diabetes self-management in a Latino social environment", Diabetes Educ, 35, pp.285~292 (2009)
43. Weihs K, "Families, health, and behavior : a section of the commissioned report by the Committee on Health and Behavior : Research, Practice, and Policy Division of Neuroscience and Behavioral Health and Division of Health Promotion and Disease Prevention Institute of Medicine, National Academy of Sciences", Fam Syst Health, 20, pp.7~46 (2002)
44. Diabetes Prevention Program(DPP)Research Group, "The Diabetes Prevention Program(DPP) : description of lifestyle intervention", Diabetes Care, 25, pp.2165~2171 (2002)
45. Martire LM, "The"relative"efficacy of involving family in psychosocial interventions for chronic illness : are there added benefits to patients and family members?", Fam Syst Health, 23, pp.312~328 (2005)
46. Chesla CA, "Do family interventions improve health?", J Fam Nurs, 16, pp.355~377 (2010)
47. Martire LM, "Is it beneficial to involve a family member? : a meta-analysis of psychosocial interventions for chronic illness", Health Psychol, 23, pp.599~611 (2004)
48. Hartmann M, "Effects of interventions involving the family in the treatment of adult patients with chronic physical diseases : a meta-analysis", Psychother Psychosom, 79, pp.136~148 (2010)
49. Martire LM, "Review and meta-analysis of couple-oriented interventions for chronic illness", Ann Behav Med, 40, pp.325~342 (2010)
50. Vargas-Ortiz K, "Effect of a family and interdisciplinary intervention to prevent T2D : randomized clinical trial", BMC Public Health, 20, pp.97~ (2020)
51. (2013)[URL]
52. Epstein NB, "The McMaster model of family functioning", J Marital Fam Ther, 4, pp.19~31 (1978)
53. Olson DH, "Circumplex model of marital and family system : I. Cohesion and adaptability dimensions, family types, and clinical applications", Fam Process, 18, pp.3~28 (1979)
54. Smilkstein G, "Validity and reliability of the family APGAR as a test of family function", J Fam Pract, 15, pp.303~311 (1982)
55. Moos RH, "Conceptual and empirical approaches to developing family-based assessment procedures : resolving the case of the Family Environment Scale", Fam Process, 29, pp.199~211 (1990)
56. Skinner H, "Family assessment measure(FAM)and process model of family functioning", J Fam Ther, 22, pp.190~210 (2000)
57. van Esch SC, "Family communication as strategy in diabetes prevention : an observational study in families with Dutch and Surinamese South-Asian ancestry", Patient Educ Couns, 87, pp.23~29 (2012)
58. Whitford DL, "Will people with type 2 diabetes speak to family members about health risk?", Diabetes Care, 32, pp.251~253 (2009)
59. Witte K, "A meta-analysis of fear appeals : implications for effective public health campaigns", Health Educ Behav, 27, pp.591~615 (2000)
60. Qureshi N, "Informing patients of familial diabetes mellitus risk : How do they respond? : a cross-sectional survey", BMC Health Serv Res, 8, pp.37~ (2008)
61. Pijl M, "Impact of communicating familial risk of diabetes on illness perceptions and self-reported behavioral outcomes : a randomized controlled trial", Diabetes Care, 32, pp.597~599 (2009)
62. Coppola A, "The role of patient education in the prevention and management of type 2 diabetes : an overview", Endocrine, 53, pp.18~27 (2016)
63. Bergman M, "Inadequacies of current approaches to prediabetes and diabetes prevention", Endocrine, 44, pp.623~633 (2013)
64. Marin P. Allen, "Improving Collaboration among Health Communication, Health Education, and Health Literacy", NAM Perspectives, 7(7) (2017), National Academy of Medicine[DOI]
65. O’Brien MJ, "Patient perceptions about prediabetes and preferences for diabetes prevention", Diabetes Educ, 42, pp.667~677 (2016)
66. Ali MK, "A cascade of care for diabetes in the United States : visualizing the gaps", Ann Intern Med, 161, pp.681~689 (2014)
67. Buijsse B, "Risk assessment tools for identifying individuals at risk of developing type 2 diabetes", Epidemiol Rev, 33, pp.46~62 (2011)
68. Noble D, "Risk models and scores for type 2 diabetes : systematic review", BMJ, 343, pp.d7163~ (2011)
69. Anderson ZL, "Management of prediabetes : a comparison of the treatment approaches utilized by a family practice clinic and an internal medicine", endocrinology practice, 2015, pp.28, 86~92
70. Ono S, "Impact of clinic follow-up visits on body weight control in people with prediabetes or diabetes mellitus : Japanese nonelderly cohort study", Fam Pract, 34, pp.552~557 (2017)
71. Jellinger PS, "American Association of Clinical Endocrinologists’ guidelines for management of dyslipidemia and prevention of atherosclerosis", Endocr Pract 2012;18 Suppl, 18(Suppl 1), pp.1~78 (2012)

관련 논문AI추천